Diagnostics magnate Alere has hooked up with the Bill and Melinda Gates Foundation to develop a tuberculosis assay and support its point-of-care HIV test.
Allergan, Cerner, Waters, Alere, Invacare, Integra Lifescience and Misonex are just a few of the medical device companies passing on the cost of the industry's 2.3% excise tax onto their hospital customers, and a major hospital purchasing group wants you to know about it.
Alere ($ALR) says its fourth quarter 2012 net revenue surged to nearly $756 million, up substantially from $651 million over the same period in 2011, thanks in part to acquisitions in the diagnostics space.
When industry folks look back at 2012, they may well see it as the year that diagnostics companies reached a rock-star-like status in the life sciences industry. Check out the report >>
The FDA is taking Alere ($ALR) to task for not acting fast enough to address manufacturing problems with its Triage cardiac diagnostic products.
Diagnostics company Alere says it has reached an agreement with the FDA over production of its Triage cardiac tests, after recalling thousands of the kits in May over quality control concerns.
Diagnostics firm Alere reported sales growth in most of its units in the second quarter, but all that was negated by charges and the fallout from its heart test recall.
Alere ($ALR) has entered uncertain territory this week as it launches a recall for 104 lots of its cardiac diagnostic tests (803,000 in all), following FDA concerns over quality control methods used in their production.
More than 800,000 heart meters used to detect heart attacks are being recalled by Waltham, MA-based Alere ($ALR) after FDA inspectors found manufacturing and labeling issues at its San Diego plant.
Axis-Shield has agreed to provide an Afinion analyzer for each of the approximately 600 CVS MinuteClinic locations in the U.S. so diabetes patients can obtain access to hemoglobin A1c test results